Changeflow GovPing Healthcare Glaucoma Shunts and Related Methods of Use - US...
Routine Notice Added Final

Glaucoma Shunts and Related Methods of Use - US12594187B2

Favicon for changeflow.com USPTO Patent Grants - Prosthetics (A61F)
Published
Detected
Email

Summary

USPTO granted patent US12594187B2 to Hexiris Inc. for glaucoma shunts and associated methods of use. The patent covers elongate bodies with inner walls defining lumens for draining aqueous humour to decrease intraocular pressure in eyes. The patent contains 8 claims and is classified under CPC codes A61F 9/00781 and related ophthalmic categories.

What changed

USPTO issued patent grant US12594187B2 to Hexiris Inc. covering glaucoma shunts with elongate bodies defining lumens for aqueous humour drainage and methods for decreasing intraocular pressure by inserting the shunt into the anterior chamber of the eye. The patent names inventors Houfar Sekhavat and Nir Shoham-Hazon with a filing date of June 17, 2025.

Patent grants establish enforceable intellectual property rights but do not create immediate compliance obligations for third parties. Medical device manufacturers developing similar intraocular pressure management products should consider potential patent claims when designing competing devices to avoid infringement. The 8 granted claims provide Hexiris Inc. exclusive rights to the disclosed shunt designs and methods.

What to do next

  1. Monitor for updates

Archived snapshot

Apr 7, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Glaucoma shunts and related methods of use

Grant US12594187B2 Kind: B2 Apr 07, 2026

Assignee

Hexiris Inc.

Inventors

Houfar Sekhavat, Nir Shoham-Hazon

Abstract

Glaucoma shunts including an elongate body with an outer surface and an inner surface, the elongate body comprising an inner wall that defines a lumen spanning a length of the elongate body are disclosed herein. Also disclosed are methods of decreasing intraocular pressure in an eye, the method comprising inserting at least a portion of a glaucoma shunt into an anterior chamber of the eye, and draining aqueous humour from the anterior chamber through the lumen.

CPC Classifications

A61F 9/00781 A61F 9/0017 A61F 9/007 A61F 2009/00891 A61F 2/14 A61F 2009/00865 A61F 2009/00868 A61B 17/3468 A61B 1/0052 A61M 27/002 A61M 2210/0612 A61M 25/0105 A61M 25/0147 A61M 37/0069

Filing Date

2025-06-17

Application No.

19240693

Claims

8

View original document →

Get daily alerts for USPTO Patent Grants - Prosthetics (A61F)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 7th, 2026
Instrument
Notice
Legal weight
Binding
Stage
Final
Change scope
Minor
Document ID
US12594187B2

Who this affects

Applies to
Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Patent grant issuance Medical device IP Intraocular device manufacturing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices

Get alerts for this source

We'll email you when USPTO Patent Grants - Prosthetics (A61F) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!